BGLC: BioNexus Gene Lab Corp insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13D stake | Tan Lee Su-Leng | 11.50% | SEC |
Institutional ownership (Q2 2026)
3 institutions reported holding $226 of BioNexus Gene Lab Corp on Form 13F (2 the quarter before). 2 opened a new position and 1 sold out. Shares held by institutions: +6100%.
| Largest holders | Shares | Value |
|---|---|---|
| UBS Group AG | 101 | $197 |
| HRT FINANCIAL LP | 14,283 | $27 |
| Caitong International Asset Management Co., Ltd | 1 | $2 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.